Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 349

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

Open access
Rudolph, Volker, Andrié, René P, Rudolph, Tanja K, Friedrichs, Kai, Klinke, Anna, Hirsch-Hoffmann, Birgit, Schwoerer, Alexander P, Lau, Denise, Fu, XiaoMing, Klingel, Karin, Sydow, Karsten, Didié, Michael, Seniuk, Anika, von Leitner, Eike-Christin, Szoecs, Katalin, Schrickel, Jan W, Treede, Hendrik, Wenzel, Ulrich, Lewalter, Thorsten, Nickenig, Georg, Zimmermann, Wolfram-Hubertus, Meinertz, Thomas, Böger, Rainer H, Reichenspurner, Hermann, Freeman, Bruce A, Eschenhagen, Thomas, Ehmke, Heimo, Hazen, Stanley L, Willems, Stephan, Baldus, Stephan·2010·Nature Medicine
DOI 10.1038/nm.2124
Open this paper in CoChat — free account

Abstract

Observational clinical and ex vivo studies have established a strong association between atrial fibrillation and inflammation. However, whether inflammation is the cause or the consequence of atrial fibrillation and which specific inflammatory mediators may increase the atria's susceptibility to fibrillation remain elusive. Here we provide experimental and clinical evidence for the mechanistic involvement of myeloperoxidase (MPO), a heme enzyme abundantly expressed by neutrophils, in the pathophysiology of atrial fibrillation. MPO-deficient mice pretreated with angiotensin II (AngII) to provoke leukocyte activation showed lower atrial tissue abundance of the MPO product 3-chlorotyrosine, reduced activity of matrix metalloproteinases and blunted atrial fibrosis as compared to wild-type mice. Upon right atrial electrophysiological stimulation, MPO-deficient mice were protected from atrial fibrillation, which was reversed when MPO was restored. Humans with atrial fibrillation had higher plasma concentrations of MPO and a larger MPO burden in right atrial tissue as compared to individuals devoid of atrial fibrillation. In the atria, MPO colocalized with markedly increased formation of 3-chlorotyrosine. Our data demonstrate that MPO is a crucial prerequisite for structural remodeling of the myocardium, leading to an increased vulnerability to atrial fibrillation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm.2124

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 349

Metadata

Authors
Rudolph, V., Andrié, R. P., Rudolph, T. K., Friedrichs, K., Klinke, A., Hirsch-Hoffmann, B., Schwoerer, A. P., Lau, D., Fu, X., Klingel, K., Sydow, K., Didié, M., Seniuk, A., von Leitner, E.-C., Szoecs, K., Schrickel, J. W., Treede, H., Wenzel, U., Lewalter, T., Nickenig, G., Zimmermann, W.-H., Meinertz, T., Böger, R. H., Reichenspurner, H., Freeman, B. A., Eschenhagen, T., Ehmke, H., Hazen, S. L., Willems, S., & Baldus, S.
Venue
Nature Medicine
Publisher
Springer Science and Business Media LLC
Published
2010-03-21
Volume
16
Issue
4
Pages
470-474
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
DOI
10.1038/nm.2124
OpenAlex
W1979480120
Cited by
349
References
38
FWCI
11.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. https://app.cochat.ai/papers/10.1038/nm.2124
The paper
Rudolph, V., Andrié, R. P., Rudolph, T. K., Friedrichs, K., Klinke, A., Hirsch-Hoffmann, B., Schwoerer, A. P., Lau, D., Fu, X., Klingel, K., Sydow, K., Didié, M., Seniuk, A., von Leitner, E.-C., Szoecs, K., Schrickel, J. W., Treede, H., Wenzel, U., Lewalter, T., . . . Baldus, S. (2010). Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nature Medicine. https://doi.org/10.1038/nm.2124

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.